Abstract

Background: Opioid analgesics, widely used to treat acute, postoperative, and chronic pain, can result in severe respiratory depression.1–3 Can tandospirone, a novel nonbenzodiazepine anxiolytic/antidepressant drug and selective serotonin-1A receptor partial agonist, counter fentanyl-induced respiratory depression?

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call